GPT and metabolic dysfunction-associated steatohepatitis: Pioglitazone treatment reduces hepatic fat contents in type 2 diabetic subjects and ameliorates nonalcoholic steatohepatitis (NASH) accompanied by reduced blood levels of TG, alanine aminotransferase, and aspartate aminotransferase [31], [33], [34].